The identification of disease related autoantigens targeted by pathogenic T-and B-cell responses is crucial for the development of improved therapies for autoimmune diseases. To identify immunogenic targets recognized by the humoral immune response, we have recently applied a novel and powerful molecular approach, named 'Serological antigen selection'. This method involves the display of a cDNA expression library on filamentous phage and subsequent selection on patient Immunoglobulin G (IgG). In the present study, we have cloned a cDNA repertoire from a Multiple Sclerosis (MS) patient in pVI phage display vectors and performed selections on pooled MS cerebrospinal fluid samples (CSF) immobilized with anti-human IgG. To further streamline this procedure, we report an optimized SAS procedure in which we have successfully established methods for enrichment of MS-specific candidate antigens. In conclusion, the broad applicability of the SAS method makes it a highly promising method for investigating the autoimmune repertoire.
INTRODUCTION
The identification of B and T cell epitopes is a crucial step for the understanding of the immune response mechanisms and their role in autoimmune diseases. Although some autoimmune diseases have been mainly considered as T-cell mediated diseases, the importance of autoreactive B cells has long been underestimated. However, the number of autoimmune diseases associated with the presence of autoantibodies directed against cells of the target tissue has been growing extensively over the past years [1, 2, 3, 4] . Therefore, the role of B cells and antibodies has been re-evaluated in several autoimmune diseases such as multiple sclerosis.
Multiple sclerosis is a chronic, inflammatory disease of the central nervous system characterized by multifocal inflammation and destruction of myelin. Although the etiology is unknown, it is generally accepted that a misdirected immune response plays a crucial role in the pathogenesis of the disease. Several findings suggest an important role of B cells and autoantibodies in MS. In chronic MS lesions, B cells, plasma cells and antibodies have been demonstrated [5, 6] . Analysis of the heavy chain repertoire of B cells in the central nervous system revealed a limited Immunoglobulin G (IgG) repertoire, which is consistent with a targeted immune response [7, 8, 9, 10] . In addition, cerebrospinal fluid (CSF) of patients with clinically definite MS is characterized by the presence of oligoclonal antibodies (seen as oligoclonal bands), which is used as a diagnostic indicator of disease [11] . Accordingly, in the serum, where these bands are not observed using isoelectric focusing, the same antibodies should be either absent, or, if present, not quantitatively predominant.
The isolation of autoantigens recognized by autoantibodies present in e.g. sera from patients with autoimmune diseases has been traditionally carried out through time-consuming processes. One of the first methods described used immunoprecipitation and immunoblotting to identify candidate autoantigens [12, 13] . More recent procedures focused on the serological screening of cDNA libraries constructed with lambda phage vectors [14] . Although this procedure has led to successful applications in several autoimmune diseases [15, 16, 17] , the labor intensity and non-quantitative nature of the screening procedure have impeded the analysis of many different candidate autoantigens on multiple normal and patient sera.
During the past decade, filamentous phage display has been used to identify ligands for any type of ligate. Based on this system, random peptide libraries have been constructed and screened on different ligates such as monoclonal antibodies and even more complex patient sera [18, 19, 20, 21] . However, the main disadvantage is that only antigen mimotopes are recovered by which further analysis is required to actually clone the serologically defined antigen. In multiple sclerosis, the use of random peptide libraries has mainly resulted in the isolation of candidate peptides which showed patient specific immunoreactivity [22, 23] .
To fully explore the complex information present within the antibody repertoire of patients, we have recently applied a novel and powerful molecular approach, called 'Serological antigen selection'. This method involves the display of a cDNA expression library on filamentous phage by fusing the cDNA product to minor coat protein pVI [24] . The filamentous phage links the expressed and displayed cDNA product to the DNA, cloned into the phage genome. This allows the selection and enrichment of those cDNA products that interact with a chosen immobilized or labeled ligand, for example, patient IgG. We have successfully applied this method to molecularly define antigens recognized by the humoral immune system in colorectal cancer, and this gave rise to the isolation of a panel of candidate tumor antigens in colorectal cancer [25] .
The present study reports the cloning and display of an MS cDNA library from the target tissue on filamentous phage and enrichment by affinity selection on MS patient CSF and serum IgG. By using the patient's autoantibody repertoire to identify those cDNA expression products or antigens that evoke an IgG immune response, interesting candidates can be identified for further study. To further streamline this procedure, we report an optimized SAS procedure in which we have successfully established methods for enrichment of MS-specific candidate antigens. A panel of antigenic cDNAs with an MS-related immunogenicity holds promise as a valuable tool in a diagnostic setting.
MATERIALS AND METHODS

Cloning of an MS cDNA library for pVI display
A normalized cDNA library (1.0 x 10 6 primary recombinants) derived from active chronic MS plaques, with varying degrees of demyelination and inflammatory activity (gift from Dr. Soares) was transferred into our phage cDNA display vectors, named pSPVIA, pSPVIB and pSPVIC, each encoding one of three reading frames. The normalized cDNA library was prepared following a procedure based on reassociation kinetics [26] . 
CSF/Sera
Cerebrospinal fluid samples and sera were obtained from MS patients and patients with other inflammatory (meningitis, polyneuropathy) and non-inflammatory neurological disorders (hernia, epilepsy, dementia, …). In addition, sera were collected from healthy volunteers. CSF and serum samples were stored at -80°C after collection. CSF and serum samples used for the selection procedure were absorbed against E. Coli and phage antibodies by repeated passage through columns of Sepharose 6MB (Pharmacia, Uppsala, Sweden) coupled to lysates of E. Coli Y1090 and bacteriophage-infected E. Coli XL1Blue. Following absorption steps, aliquots from CSF and serum samples were prepared in 0.2% (w/v) skimmed milk powder in 1 x TBS (50 mM Tris-HCl (pH 7.9) and 150 mM NaCl) and stored at -20°C.
Selection of phage pVI displayed cDNA repertoires
CSF samples of 10 untreated relapsing remitting (RR) MS patients (8 women, 2 men, age 32-51, EDSS 0-3.5) were pooled and used for affinity selections. Selections were performed as described before with slight adaptations [25] . In brief, immunotubes (Nunc, Roskilde, Denmark) were coated with rabbit anti-human IgG (Dako, Glostrup, Denmark) at a concentration of 10 µg/ml in coating buffer (0.1M sodium hydrogen carbonate pH 9.6) for 2 hours at 37ºC. After washing the immunotube twice with phosphate-buffered saline/Tween 20 (PBST: 50 mM Tris, 150 mM NaCl, PH 7.5, 0.1% Tween 20 (w/v)) and twice with PBS, the tubes were blocked for 2 hours at room temperature (RT) with 2% MPBS (2% w/v milk powder in PBS). Phage were prepared from each library MS-pSPVIA, MS-pSPVI6B and MSpSPVIC as described previously [27] . Approximately equal numbers of phage derived from each phage library (±2 x 10 12 pfu) were added to pooled CSF (1:5 diluted in 4% MPBS) and incubated in a glass tube for 1.5 hour at RT on a rotating platform. After washing the coated immunotube twice with PBST and twice with PBS, the preincubated CSF and phage mix was transferred to the coated immunotube and incubated for 30 minutes on a rotating platform and 120 minutes standing at RT. Tubes were then washed 20 times with PBST and 20 times with PBS to remove non-binding phage. Binding phage were eluted with 100 mM triethylamine and neutralized with 1M Tris HCl as described before [25] . E. Coli TG1 cells were infected with input and output phage and plated on 2 x TY agar plates containing ampicillin and glucose (16 g/l bacto-tryptone, 10 g/l yeast extract, 5 g/l NaCl, 15 g bacto-agar/l, ampicillin at 100 µg/ml and glucose at 2% w/v) at each round of selection. Resultant colonies were scraped and phage were rescued for further rounds of affinity selections. To monitor enrichment of specific clones, input and output phage from each round of selection were titrated and the ratio of output/input phage was determined.
Depletion strategies of non-specific clones
To enrich for selection of cDNA products binding to IgGs specifically associated with MS, alternative selection strategies on MS patient material and normal samples were tested.
After a first selection round on a pool of 10 RR MS sera, a depletion strategy was developed by using a pool of 10 age-matched normal sera. Selections on the pool of MS sera (1/100 diluted in 4% MPBS) were performed as described above. After this first selection round, phage were rescued and used for selection on IgGs present in the pool of age-matched normal sera (1/100 diluted in 4% MPBS). After preincubation for 1.5 hour at RT on a rotating platform, the mixture was transferred to the coated immunotube for 30 minutes on a rotating platform and 120 minutes standing at RT, the non-bound phage was now recovered and used for infection of E. Coli TG1 cells. Phage were again rescued as described and the selection process of alternative selections on MS patient and normal sera was repeated. The ratio of output/input phage was determined after each selection round.
Polymerase chain reaction (PCR) amplification and fingerprinting
After several rounds of selection, individual colonies were selected and the insert size was determined with forward primer (5'-CTC TCT GTA AAG GCT GC-3') and reverse primer ( 
RESULTS
Construction and enrichment of a phage displayed MS cDNA library with MS CSF
A normalized cDNA library derived from active, chronic MS plaques, with varying degrees of demyelination and inflammatory activity, which was originally cloned into the pT7T3-Pac vector, was cloned into the pVI display vectors in 3 reading frames. A total library size of 1.1 x 10 7 colony forming units (cfu) was obtained. Analysis of 50 random clones from each library indicated insert sizes of the MS-cDNA repertoire ranging from 500 bp to 2.5 kb.
CSF samples from 10 RR MS patients were used for selections against a polyclonal rabbit anti-human IgG. We decided to pool patient material for the selection procedure because previous applications using peptide libraries resulted in the identification of clones which showed patient specific reactivity [22, 23] . The procedure of 'Serological Antigen Selection' (SAS) is depicted in Figure 1 The results of affinity selection of the pVI phage displayed MS cDNA library on the pool of MS patient CSF are presented in Table 1 . Following rescue of the phage clones after each of 4 rounds of selection, enrichment of phage could be seen reflected in an increase of the ratio output to input phage titer. Fingerprint analysis of the clones from the fourth round of selection showed that many different cDNA products had been selected, which also indicated that selective enrichment had occurred (data not shown). Although many cDNA products were successfully identified, a relatively high number (> 50%) of cDNAs were retrieved that encoded for IgG transcripts. These originated from B cells present in the MS brain used to construct the primary cDNA library. The insert sizes of the genes ranged from 600 to 2500 bp and remained constant during selection cycles.
Results from depletion strategies
In order to enhance the selection of cDNA products binding to IgGs specifically associated with MS, an optimization strategy was designed including alternative selections on MS patient material and normal samples. This method was illustrated using MS patient and normal sera. By repeated selections on MS patient sera and normal sera, the enrichment of cDNA clones encoding for IgG transcripts was dramatically decreased to > 50% of that without depleting steps (Table 2) . Together with the IgG transcripts, a high number of phage clones binding to normal sera was retrieved in the depletion step, thereby increasing the identification of clones related to MS patient sera (data not shown). This improved approach allows the identification of candidate MS clones recognized by IgGs present in sera of MS patients (manuscript in preparation).
Phage ELISA screening of antigens retrieved by the MS CSF pool
In the first selection experiment we used pooled CSF from RR MS patients as selector. 
DISCUSSION
Despite the apparent diversity of proteins that can be displayed on filamentous phage, the generation of representative cDNA libraries and selections on complex patient material has presented a substantial challenge. To apply this technology to autoimmune diseases like MS, optimal conditions for technology design and handling of patient material are inevitable.
Both vector design and the method of library construction have important implication for the quality and diversity of the repertoire that can be displayed. Firstly, cDNA repertoires should be cloned in all reading frames and in a defined orientation. Secondly, selections under conditions of low selective pressure require a highly stable vector system. To further permit the isolation of very rare transcripts, a cDNA library size containing at least 10 6 independent clones is necessary, but even larger repertoires are required when fragment repertoires are constructed. In addition, the presence of IgG transcripts, which hamper the identification of relevant candidate autoantigens, should be overcome by optimizing depleting strategies.
The present study clearly demonstrates that selection of phage-cDNAs on MS patient CSF and sera provides a fast molecular procedure for analyzing the humoral immune response. In addition, using SAS in MS patients, we have optimized the selection procedure, which allows the identification of possible candidate autoantigens by first depleting for the presence of IgG transcripts.
The cloning and selection of an MS cDNA library displayed as fusion to the Cterminus of the minor coat protein VI proved to be successful. In contrast to bacteriophage coat protein 3 (pIII) or 8 (pVIII), the phage coat protein pVI is not known to be involved in infection and has the characteristic that the C-terminus rather than the N-terminus is believed to be surface-exposed [28] . Therefore, the possible advantage of pVI for the display of cDNA repertoires is that the presence of stop codons does not prevent display. Furthermore, the use of a normalized cDNA library of 10 6 primary recombinants, directionally cloned in all 3 reading frames, has proven to give a representative library size.
To further improve the diversity of the library, one may perform selections on a The greater simplicity and speed of this serological assay allows the rapid screening of other disease-related and autoimmune CSF and sera together with a control group consisting of healthy individuals which have been age/sex matched. These characteristics make the phage display method far superior over the SEREX screening procedure. In future, this enables high-throughput serological immunome mapping with the use of age-matched databases and autoimmune databases. Correlations may be made for MS type versus characterization of multiple clones in a fast and cost-effective way, high-throughput screening is required, by which the need for cDNA protein screening (arrays) is inevitable.
In conclusion, Serological Antigen Selection i) is amenable to high throughput analysis, ii) yields a molecular profile of antibody-inducing antigens, and iii) may identify disease-related (auto)antigens, early detection of changes in immune responses due to infection, and possibly even surrogate markers for disease of unknown etiology. 
